PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCT
NCT04158804 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 700
Last updated 2025-03-20
Summary
Trials comparing PCT-guided antibiotic algorithms to standard management show a significant reduction in antibiotic exposure without an increase in mortality or treatment failure. Despite this strong evidence from multiple studies a recent prospective multicentric interventional trial in the US fell short of demonstrating antibiotic reductions by PCT-guided antibiotic management. Amongst other limitations the authors of that study concluded that successful implementation of PCT may require closer educational oversight. As such, this study will compare effectiveness and safety of antibiotic prescription guided by a PCT-algorithm via a Stewardship Team over standard guidelines in hospitalized adult patients with suspected or confirmed LRTI (including sepsis with respiratory focus).
Conditions
- Pneumonia, Bacterial
Interventions
- DIAGNOSTIC_TEST
-
procalcitonin
accuracy of procalcitonin as a diagnostic marker in guiding antibiotic therapy in patients with a lower respiratory tract infection
Sponsors & Collaborators
-
BRAHMS GmbH
collaborator UNKNOWN -
Thermo Fisher Scientific, Inc
collaborator INDUSTRY -
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Michael K Mansour, MD, PhD · Massachusetts General Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 110 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-05-28
- Primary Completion
- 2023-06-17
- Completion
- 2023-06-17
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia
NCT03452826 ·Status: COMPLETED ·Phase: NA
-
Procalcitonin-Guided Antibiotic Therapy in Bronchiectasis
NCT03058718 ·Status: COMPLETED ·Phase: NA
-
PCT-guided Treatment Regarding Antibiotic Use for Acute COPD Exacerbations
NCT05854901 ·Status: UNKNOWN ·Phase: NA
-
An Algorithm to Decide on Antibiotic Prescription in Lower Respiratory Tract Infection in Primary Care
NCT03191071 ·Status: COMPLETED ·Phase: NA
-
Use Of Procalcitonin Level For Guidance of The Treatment of Suspected Community Acquired Pneumonia
NCT00914550 ·Status: COMPLETED
-
The Procalcitonin Guided Antibiotics in Respiratory Infections in General Practice
NCT04216277 ·Status: WITHDRAWN ·Phase: NA
-
Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)
NCT04999592 ·Status: TERMINATED ·Phase: PHASE2
-
Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis
NCT06977165 ·Status: NOT_YET_RECRUITING
-
Procalcitonin at Zero and 24 Hours as a Prognostic Factor in Patients With Pneumonia
NCT03711227 ·Status: COMPLETED
-
Procalcitonin Versus C-reactive Protein to Guide Therapy in Community Acquired Pneumonia
NCT01018199 ·Status: WITHDRAWN ·Phase: NA
-
Procalcitonin as a Marker of Antibiotic Therapy in Patients With Lower Respiratory Tract Infections
NCT02171338 ·Status: UNKNOWN ·Phase: PHASE4
-
A Trial of Procalcitonin in Patients With Acute Exacerbation of Chronic Obstructive Pulmonary Disease
NCT04682899 ·Status: UNKNOWN ·Phase: PHASE3
-
Procalcitonin to Reduce Antibiotic Use in Pediatric Pneumonia
NCT04963764 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Reduction the Duration of Antibiotic Therapy in the Elderly (PROPAGE)
NCT02173613 ·Status: TERMINATED ·Phase: NA
-
Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room
NCT05657275 ·Status: COMPLETED ·Phase: NA
-
POCT PCT in Outpatient LRTI
NCT05380869 ·Status: COMPLETED ·Phase: NA
-
Point of Care Polymerase Chain Reaction (PCR) Diagnostics of Respiratory Tract Infections in General Practice
NCT06120153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Biomarker Guided Antibiotic Treatment in Community-Acquired Pneumonia
NCT03146182 ·Status: UNKNOWN ·Phase: NA
-
Procalcitonin To Reduce Antibiotics in Chronic Obstructive Lung Disease (ProToCOLD)
NCT01950936 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
PROcalcitonin Pneumonia / Pneumonitis Associated With ASPIration
NCT02862314 ·Status: COMPLETED ·Phase: PHASE4
-
Use of a Respiratory Multiplex PCR and Procalcitonin to Reduce Antibiotics Exposure in Patients With Severe Confirmed COVID-19 Pneumonia
NCT04334850 ·Status: COMPLETED ·Phase: NA
-
Comparison of a Serum PRO-CT Guided Treatment and the Recommended Antibiotic Treatment for COPD
NCT01125098 ·Status: COMPLETED
-
Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in Adults
NCT01940731 ·Status: UNKNOWN ·Phase: PHASE2
-
Use of MULTIplex PCR, Procalcitonin, and Sputum Appearance to Reduce Duration of Antibiotic Therapy During Severe COPD EXAcerbation: A Controlled, Randomized, Open-label, Parallel-Group, Multicenter Trial
NCT05280132 ·Status: RECRUITING ·Phase: NA
-
Efficacy and Safety of a Protocol Using C-reactive Protein to Guide Antibiotic Therapy
NCT05841875 ·Status: COMPLETED ·Phase: NA